Skip to main content
Erschienen in: Annals of Nuclear Medicine 3/2015

01.04.2015 | Original Article

Differentiation of an adrenal mass in patients with non-small cell lung cancer by means of a normal range of adrenal standardized uptake values on FDG PET/CT

verfasst von: Bom Sahn Kim, Jong Doo Lee, Won Jun Kang

Erschienen in: Annals of Nuclear Medicine | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Object

The aim of this study was to assess the range of normal adrenal FDG uptake, and to determine the diagnostic criteria of FDG PET-CT to differentiate adrenal nodule.

Methods

A total of 117 healthy subjects who underwent FDG PET/CT for cancer screening, and 106 lung cancer patients who underwent FDG PET/CT for cancer staging without adrenal abnormality were enrolled to determine the normal range of adrenal standardized uptake value (SUV). In addition, another 24 lung cancer patients with suspicious adrenal masses were enrolled to evaluate the diagnostic performance of the different diagnostic criteria from FDG PET/CT.

Results

The adrenal maximal SUV (SUVmax) of the healthy group was 1.66 ± 0.21 in the right and 1.86 ± 0.30 in the left. The adrenal SUVmax of lung cancer group was 1.79 ± 0.30 in the right and 1.90 ± 0.37 in the left. Lung cancer group had a higher ratio of adrenal gland to liver (AL ratio) when compared with healthy subjects (0.77 ± 0.13 vs. 0.61 ± 0.10 on the right, 0.82 ± 0.12 vs. 0.68 ± 0.12 on the left: p < 0.001). The upper normal limits of adrenal SUVmax were calculated as the mean plus 2 standard deviations (right: 2.08 vs. 2.39, left: 2.46 vs. 2.64, in the normal group and lung cancer group, respectively). Using the upper limit from the lung cancer group, we achieved a sensitivity of 87 % and specificity of 100 %.

Conclusion

We demonstrated that left adrenal gland had higher SUV than right adrenal gland both in healthy group and lung cancer group. Using the different normal range of bilateral adrenal SUVmax, we could successfully differentiate adrenal masses.
Literatur
1.
Zurück zum Zitat Barzon L, Sonino N, Fallo F, Palu G, Boscaro M. Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol. 2003;149:273–85.CrossRefPubMed Barzon L, Sonino N, Fallo F, Palu G, Boscaro M. Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol. 2003;149:273–85.CrossRefPubMed
2.
Zurück zum Zitat Ettinghausen SE, Burt ME. Prospective evaluation of unilateral adrenal masses in patient with operable non-small cell lung cancer. J Clin Oncol. 1991;9:462–6. Ettinghausen SE, Burt ME. Prospective evaluation of unilateral adrenal masses in patient with operable non-small cell lung cancer. J Clin Oncol. 1991;9:462–6.
3.
Zurück zum Zitat Welch TJ, Sheedy PF, Stephens DH, Johnson CM, Swensen SJ. Percutaneous adrenal biopsy: review of a 10-year experience. Radiology. 1994;193:341–4.CrossRefPubMed Welch TJ, Sheedy PF, Stephens DH, Johnson CM, Swensen SJ. Percutaneous adrenal biopsy: review of a 10-year experience. Radiology. 1994;193:341–4.CrossRefPubMed
4.
Zurück zum Zitat Dunnick NR, Korobkin M, Francis I. Adrenal radiology: distinguishing benign from malignant adrenal masses. AJR Am J Roentgenol. 1996;167:861–7.CrossRefPubMed Dunnick NR, Korobkin M, Francis I. Adrenal radiology: distinguishing benign from malignant adrenal masses. AJR Am J Roentgenol. 1996;167:861–7.CrossRefPubMed
5.
Zurück zum Zitat Korobkin M, Brodeur FJ, Yutzy GG, Francis IR, Quint LE, Dunnick NR, et al. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR Am J Roentgenol. 1996;166:531–6.CrossRefPubMed Korobkin M, Brodeur FJ, Yutzy GG, Francis IR, Quint LE, Dunnick NR, et al. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR Am J Roentgenol. 1996;166:531–6.CrossRefPubMed
6.
Zurück zum Zitat Mitchell DG, Crovello M, Matteucci T, Petersen RO, Miettinen MM. Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology. 1992;185:345–51.CrossRefPubMed Mitchell DG, Crovello M, Matteucci T, Petersen RO, Miettinen MM. Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology. 1992;185:345–51.CrossRefPubMed
7.
Zurück zum Zitat Korobkin M, Lombardi TJ, Aisen AM, Francis IR, Quint LE, Dunnick NR, et al. Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging. Radiology. 1995;197:411–8.CrossRefPubMed Korobkin M, Lombardi TJ, Aisen AM, Francis IR, Quint LE, Dunnick NR, et al. Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging. Radiology. 1995;197:411–8.CrossRefPubMed
8.
Zurück zum Zitat Kumar R, Xiu Y, Yu JQ, Takalkar A, El-Haddad G, Potenta S, et al. 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer. J Nucl Med. 2004;45:2058–62.PubMed Kumar R, Xiu Y, Yu JQ, Takalkar A, El-Haddad G, Potenta S, et al. 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer. J Nucl Med. 2004;45:2058–62.PubMed
9.
Zurück zum Zitat Metser U, Miller E, Lerman H, Lievshitz G, Avital S, Even-Sapir E. 18F-FDG PET/CT in the evaluation of adrenal masses. J Nucl Med. 2006;47:32–7.PubMed Metser U, Miller E, Lerman H, Lievshitz G, Avital S, Even-Sapir E. 18F-FDG PET/CT in the evaluation of adrenal masses. J Nucl Med. 2006;47:32–7.PubMed
10.
Zurück zum Zitat Jana S, Zhang T, Milstein DM, Isasi CR, Blaufox MD. FDG-PET and CT characterization of adrenal lesions in cancer patients. Eur J Nucl Med Mol Imaging. 2006;33:29–35.CrossRefPubMed Jana S, Zhang T, Milstein DM, Isasi CR, Blaufox MD. FDG-PET and CT characterization of adrenal lesions in cancer patients. Eur J Nucl Med Mol Imaging. 2006;33:29–35.CrossRefPubMed
11.
Zurück zum Zitat Bagheri B, Maurer AH, Cone L, Doss M, Adler L. Characterization of the normal adrenal gland with 18F-FDG PET/CT. J Nucl Med. 2004;45:1340–3.PubMed Bagheri B, Maurer AH, Cone L, Doss M, Adler L. Characterization of the normal adrenal gland with 18F-FDG PET/CT. J Nucl Med. 2004;45:1340–3.PubMed
12.
Zurück zum Zitat Vincent JM, Morrison ID, Armstrong P, Reznek RH. The size of normal adrenal glands on computed tomography. Clin Radiol. 1994;49:453–5.CrossRefPubMed Vincent JM, Morrison ID, Armstrong P, Reznek RH. The size of normal adrenal glands on computed tomography. Clin Radiol. 1994;49:453–5.CrossRefPubMed
13.
Zurück zum Zitat Ulrich-Lai YM, Figueiredo HF, Ostrander MM, Choi DC, Engeland WC, Herman JP. Chronic stress induces adrenal hyperplasia and hypertrophy in a subregion-specific manner. Am J Physiol Endocrinol Metab. 2006;291:E965–73.CrossRefPubMed Ulrich-Lai YM, Figueiredo HF, Ostrander MM, Choi DC, Engeland WC, Herman JP. Chronic stress induces adrenal hyperplasia and hypertrophy in a subregion-specific manner. Am J Physiol Endocrinol Metab. 2006;291:E965–73.CrossRefPubMed
14.
Zurück zum Zitat Erasmus JJ, Patz EF Jr, McAdams HP, Murray JG, Herndon J, Coleman RE, et al. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol. 1997;168:1357–60.CrossRefPubMed Erasmus JJ, Patz EF Jr, McAdams HP, Murray JG, Herndon J, Coleman RE, et al. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol. 1997;168:1357–60.CrossRefPubMed
15.
Zurück zum Zitat Shulkin BL, Thompson NW, Shapiro B, Francis IR, Sisson JC. Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-d-glucose PET. Radiology. 1999;212:35–41.CrossRefPubMed Shulkin BL, Thompson NW, Shapiro B, Francis IR, Sisson JC. Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-d-glucose PET. Radiology. 1999;212:35–41.CrossRefPubMed
16.
Zurück zum Zitat Brady MJ, Thomas J, Wong TZ, Franklin KM, Ho LM, Paulson EK. Adrenal nodules at FDG PET/CT in patients known to have or suspected of having lung cancer: a proposal for an efficient diagnostic algorithm. Radiology. 2009;250:523–30.CrossRefPubMed Brady MJ, Thomas J, Wong TZ, Franklin KM, Ho LM, Paulson EK. Adrenal nodules at FDG PET/CT in patients known to have or suspected of having lung cancer: a proposal for an efficient diagnostic algorithm. Radiology. 2009;250:523–30.CrossRefPubMed
Metadaten
Titel
Differentiation of an adrenal mass in patients with non-small cell lung cancer by means of a normal range of adrenal standardized uptake values on FDG PET/CT
verfasst von
Bom Sahn Kim
Jong Doo Lee
Won Jun Kang
Publikationsdatum
01.04.2015
Verlag
Springer Japan
Erschienen in
Annals of Nuclear Medicine / Ausgabe 3/2015
Print ISSN: 0914-7187
Elektronische ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-014-0937-3

Weitere Artikel der Ausgabe 3/2015

Annals of Nuclear Medicine 3/2015 Zur Ausgabe